{
  "id": 18206252,
  "title": "How a CRISPR sickle cell therapy moved from lab to clinical trial",
  "url": "https://urgent.news/2026/11/04/how-a-crispr-sickle-cell-therapy-moved-from-lab-to-clinical-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T23:20:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-crispr-sickle-cell-therapy-lab.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}